Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin

Cell Death and Differentiation

Volumn 15, Issue 4, 2008, Pages 783-792

  Byts, N ^a,b   Samoylenko, A ^a   Fasshauer, T ^a   Ivanisevic, M ^a   Hennighausen, L ^c   Ehrenreich, H ^b   Siren A L ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GLUTAMIC ACID; GROWTH HORMONE; JANUS KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; STAT5 PROTEIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FETUS; HIPPOCAMPUS; HORMONE ACTION; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHROMONES; CYTOPROTECTION; ERYTHROPOIETIN, RECOMBINANT; GLUTAMIC ACID; HIPPOCAMPUS; HUMAN GROWTH HORMONE; HUMANS; JANUS KINASE 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOLINES; NERVE GROWTH FACTORS; NEURITES; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRITERPENES;

EID: 40949134551     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.1     Document Type: Article

References (40)

1. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001; 13: 211-217.
2. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX et al. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct function in cell proliferation, survival, and differentiation. Mol Cell Biol 2004; 24: 8037-1017.
3. Markham K, Schuurmans C, Weiss S. STAT5A/B activity is required in the developing forebrain and spinal cord. Mol Cell Neurosci 2007; 35: 272-282.
4. De-Fraja C, Conti L, Magrassi L, Govoni S, Cattaneo E. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J Neurosci Res 1998; 54: 320-330.
5. Ting CH, Lin CW, Wen SL, Hsieh-Li HM, Li H. Stat5 constitutive activation rescues defects in spinal muscular atrophy. Hum Mol Genet 2007; 16: 499-514.
6. Sirén AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P et al. Erythropoietin prevents nouronal apoptosis after cerebral ischemia and metabolic stress. Proc Nat Acad Sci USA 2001; 98 4044-4049.
7. Um M, Lodish HF. Antiapoptotic effects of erythropoiefin in diffirentiated neuroblastoma SH-SY5Y calls require activation of both the STAT5 and AKT signaling pathways. J Biol Chem 2006; 281: 5648-5656.
8. Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B et al. Erythropoietin receptor signalling is required for normal brain development. Development 2002; 129: 505-516.
9. Zhang F, Wang S, Cao G, Gao Y, Chen J. Signal transducers and activators of transcription 5 contributes to orythropoiefin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia. Neurobiol Dis 2007; 25: 45-53.
10. Liu J, Narasimhan P, Yu F, Chan PH. Neuroprotection, by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and arythropoietin. Stroke 2005; 36 1264-1269.
11. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 2005; 6: 484-494.
12. Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 2001; 21: 9733-9743.
13. Chong ZZ, Li F, Maiese K Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2005; 2 387-399.
14. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001; 412: 641-647.
15. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Brain-derived erythropoietin protects from local cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 2005; 19 2026-2028.
16. Malhotra 8, Savitz SI, Ocava L, Rosenbaum DM. Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 2006; 83: 19-27.
17. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: Evidence from an in vitro model. J Neurosci 2002; 22: 10291-10301.
18. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM. Discovery of JSI-124 (cucurbitacin 1), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity againts human and murine cancer cells in mice. Cancer Res 2003; 63: 1270-1279.
19. Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM. Cucurbitacin Q: A selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 2005; 24: 3236-3245.
20. Klover P, Hennighausen L. Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle: A role for autocrine/paracrine insulin-like growth factor 1. Endocrinology 2007; 148: 1489-1497.
21. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003; 349: 1139-1147.
22. Liu XB, Murray KD, Jones EG. Switchiing of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development. J Nourosci 2004; 24: 8885-8895.
23. Brewer LD, Thibault 0, Staton J, Thibault V, Rogers JT, Garcia-Ramos G et al. Increased vulnerability of hippocampal neurons with age in culture: Temporal association with increases in NMDA receptor current, NR2A subunit expression and recruitment of L-type calcium channels. Brain Res 2007; 1151: 20-31.
24. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampall and cerebral cortical neurons, and arythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997; 76: 105-116.
25. Silva C, Zhang K, Tsutsui S, Holden JK, Gill MJ, Power C. Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. Ann Neural 2003; 54: 605-614.
26. Tschopp O, Yang ZZ, Brodbeck D, Dummler BA, Hemmings-Mieszczak M, Watanabe T et al. Essential role of protein kinase B gamma (PKB gamma/Akt3) in Postnatal brain development but not in glucose homeostasis. Development 2005; 132: 2943-2954.
27. Yang ZZ, Tschopp O, Di-Pol N, Bruder E, Baudry A, Dummler B et al. Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice. Mol Cell Biol 2005; 25: 10407-10418.
28. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci2002; 5: 405-414.
29. Zhou M, Baudry M. Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J Neurosci 2006; 26: 2956-2963.
30. Meloni BP, Tilbrook PA, Boulos S, Arthur PG, Knuckey NW. Erythropoietin preconditioning in neuronal cultures: Signaling, protection from in vitro ischemia, and proteomic analysis. J Neurosci Res 2006; 83: 584-593.
31. Grimm C, Wenzel A, Acar N, Killer S, Seeliger M, Gassmann M. Hypoxic preconditioning and arythropoietin protect retinal neurons from degeneration. Adv Exp Med Biol 2006; 588: 119-131.
32. Wen X, Huang Y, Wang J. Erythropoietin preconditioning on hippocampus neuronal apoptosis following status epilepticus induced by Li-pilocarpine in rats through anti-caspase-3 expression. Neurol India 2006; 54: 58-63.
33. Carter-Su C, Rui L, Herrington J. Role of the tyrosine kinase JAK2 in signal transduction by growth hormone. Pediatr nephrol 2000; 14 550-557.
34. Konishi Y, Chui DH, Hirose H, Kunishita T, Tabira T. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 1993; 609: 29-35.
35. Tabira T, Konishi Y, Gallyas Jr F. Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro. Int J Dev Neurosci 1995; 13: 241-252.
36. Wang L, Zhang ZG, Gregg SR, Zhang RL, Jiao Z, Letourneau Y et al. The sonic hedgehog pathway mediates carbamylated EPO enhanced proliferation and differentiation of adult neural progenitor cells. J Biol Chem 2007; 282: 32462-32470.
37. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004; 35: 1732-1737.
38. Ransome MI, Goldshmit Y, Bartlett PF, Waters MJ, Turnley AM. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness. Eur J Neurosci 2004; 19: 2069-2079.
39. Miller FD, Kaplan DR. Signaling mechanisms underlying dendrite formation. Curr Opin Neurobiol 2003; 13: 391-398.
40. Ludbrook J. Statistics in physiology and pharmacology: A slow and erratic learning curve. Clin Exp Pharmacol Physiol 2001; 28: 488-492.